Commonwealth Equity Services’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,019
| Closed | -$1.84M | – | 3717 |
|
|
2021
Q2 | $1.84M | Sell |
10,019
-296
| -3% | -$50.8K | ﹤0.01% | 1483 |
|
|
2021
Q1 | $1.58M | Sell |
10,315
-3,518
| -25% | -$544K | ﹤0.01% | 1486 |
|
|
2020
Q4 | $2.16M | Buy |
13,833
+613
| +5% | +$78.8K | 0.01% | 1181 |
|
|
2020
Q3 | $1.51M | Buy |
13,220
+1,751
| +15% | +$189K | 0.01% | 1250 |
|
|
2020
Q2 | $1.29M | Buy |
11,469
+500
| +5% | +$53.1K | ﹤0.01% | 1268 |
|
|
2020
Q1 | $984K | Buy |
10,969
+4,075
| +59% | +$400K | ﹤0.01% | 1277 |
|
|
2019
Q4 | $745K | Buy |
6,894
+180
| +3% | +$19.3K | ﹤0.01% | 1616 |
|
|
2019
Q3 | $657K | Sell |
6,714
-43
| -0.6% | -$4.85K | ﹤0.01% | 1631 |
|
|
2019
Q2 | $885K | Buy |
6,757
+55
| +0.8% | +$7.09K | ﹤0.01% | 1420 |
|
|
2019
Q1 | $905K | Sell |
6,702
-620
| -8% | -$77.1K | ﹤0.01% | 1366 |
|
|
2018
Q4 | $712K | Buy |
7,322
+45
| +0.6% | +$5.32K | ﹤0.01% | 1406 |
|
|
2018
Q3 | $1.01M | Sell |
7,277
-440
| -6% | -$55.2K | ﹤0.01% | 1293 |
|
|
2018
Q2 | $958K | Buy |
7,717
+81
| +1% | +$9.47K | 0.01% | 1306 |
|
|
2018
Q1 | $851K | Sell |
7,636
-102
| -1% | -$12.2K | ﹤0.01% | 1350 |
|
|
2017
Q4 | $925K | Buy |
7,738
+194
| +3% | +$23.6K | 0.01% | 1265 |
|
|
2017
Q3 | $1.06M | Sell |
7,544
-52
| -0.7% | -$7.07K | 0.01% | 1158 |
|
|
2017
Q2 | $924K | Buy |
7,596
+4,393
| +137% | +$511K | 0.01% | 1184 |
|
|
2017
Q1 | $388K | Sell |
3,203
-592
| -16% | -$76.3K | ﹤0.01% | 1682 |
|
|
2016
Q4 | $464K | Buy |
3,795
+58
| +2% | +$7.1K | ﹤0.01% | 1451 |
|
|
2016
Q3 | $458K | Sell |
3,737
-318
| -8% | -$40.9K | ﹤0.01% | 1435 |
|
|
2016
Q2 | $473K | Buy |
4,055
+281
| +7% | +$39.9K | ﹤0.01% | 1390 |
|
|
2016
Q1 | $525K | Sell |
3,774
-72
| -2% | -$10.6K | ﹤0.01% | 1292 |
|
|
2015
Q4 | $734K | Buy |
3,846
+94
| +3% | +$16.4K | 0.01% | 1087 |
|
|
2015
Q3 | $587K | Sell |
3,752
-2,028
| -35% | -$370K | 0.01% | 1164 |
|
|
2015
Q2 | $1.04M | Buy |
5,780
+423
| +8% | +$73K | 0.01% | 929 |
|
|
2015
Q1 | $928K | Buy |
5,357
+174
| +3% | +$31.5K | 0.01% | 995 |
|
|
2014
Q4 | $959K | Sell |
5,183
-1,341
| -21% | -$248K | 0.01% | 917 |
|
|
2014
Q3 | $1.08M | Buy |
6,524
+339
| +5% | +$55.7K | 0.01% | 831 |
|
|
2014
Q2 | $966K | Buy |
6,185
+16
| +0.3% | +$2.53K | 0.01% | 885 |
|
|
2014
Q1 | $938K | Sell |
6,169
-1,944
| -24% | -$309K | 0.01% | 831 |
|
|
2013
Q4 | $1.08M | Buy |
8,113
+5,749
| +243% | +$690K | 0.02% | 733 |
|
|
2013
Q3 | $275K | Sell |
2,364
-370
| -14% | -$40.6K | ﹤0.01% | 1430 |
|
|
2013
Q2 | $252K | Buy |
+2,734
| New | +$263K | ﹤0.01% | 1421 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM